Recent Finacing
Recent Raise
CG Oncology is a clinical-stage biotech developing intravesical oncolytic immunotherapies (CG0070) for non‑muscle invasive and other bladder cancers, conducting Phase 2/3 and combination trials with checkpoint inhibitors.
